期刊文献+

利伐沙班原料药中重金属镍残留量的检测方法与评价 被引量:1

Detection Method and Evaluation of Heavy Metal Nickel Residues in Rivaroxaban API
下载PDF
导出
摘要 目的:建立利伐沙班原料药中金属催化剂镍残留的两种测定方法,并对不同方法进行比较分析。方法:方法一采用石墨炉原子吸收分光光度法;方法二采用电感耦合等离子体质谱法。结果:方法一在10~100μg·L^-1范围内线性良好,最低检出浓度为1.9μg·L^-1,方法检测限为0.2μg·g^-1,加标回收率平均为112%;方法二在0.5~20μg·L^-1范围内线性良好,最低检出浓度为0.056μg·L^-1,方法检测限为0.007μg·g^-1,加标回收率平均为97.9%。结论:6批样品的检验结果表明,两种方法对结果的测量无明显差异,但电感耦合等离子体质谱法具有分析速度快、检测限更低、灵敏度高以及可多种元素同时测定等优点,在重金属痕量分析检测方面更具优势。 Objective:To establish and compare two methods for the determination of nickel residues of metal catalyst in rivaroxaban API.Methods:The method one used graphite furnace atomic absorption spectrophotometry;the method two used inductively coupled plasma mass spectrometry.Results:The method one had a good linearity in the range of 10 to 100μg·L^-1,the minimum detection concentration was 1.9μg·L^-1,the detection limit of this method is 0.2μg·g^-1 and the average recoveries were 112%.The method two had a good linearity in the range of 0.5 to 20μg·L^-1,the minimum detection concentration was 0.056μg·L^-1,the detection limit of this method was 0.007μg·g^-1 and the average recoveries were 97.9%.Conclusion:The inspection results of 6 batches of samples show that there is no significant difference between the two methods,but the inductively coupled plasma mass spectrometry has the advantages of fast analysis speed,lower detection limit,high sensitivity,and simultaneous determination of multiple elements,so it has more advantages in the analysis and detection of heavy metal traces.
作者 王宣 WANG Xuan(Huai'an Institute for Food and Drug Control,Huai'an 223001,China)
出处 《药学与临床研究》 2020年第5期338-340,共3页 Pharmaceutical and Clinical Research
关键词 利伐沙班 金属催化剂 电感耦合等离子体质谱法 石墨炉原子吸收分光光度法 Rivaroxaban Metal catalyst Nickel Inductively coupled plasma mass spectrometry Graphite furnace atomic absorption spectrophotometry
  • 相关文献

参考文献3

二级参考文献11

  • 1陈蓉,谢梅林.新型抗血栓药物作用机制研究进展[J].中国药理学通报,2004,20(8):857-860. 被引量:6
  • 2王海萍,王健伟,韩金祥,贾友苏,洪涛.因子Ⅹa抑制剂研究进展[J].生物技术通讯,2004,15(5):495-497. 被引量:3
  • 3PINTO JP D,ORWAT JM,KOCH S,et al. Discovery of 1-(4-methoxyphenyl ) -7-oxo-6-( d-( 2-oxopiperidin-1-yl ) phenyl )-4,5,6, 7-tetrahydro-1 H-pyrazolo [ 3,4-c] pyridine-3 -carboxamide ( apixa- ban, BMS-562247 ) , a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa [ J ]. J Med Chem,2007,50 ( 22 ) : 5339 - 5356.
  • 4MEDERSKI WKR W, DORSCH D, ANZALI S, et al. Halothio phenebenzimidazoles as P1 surrogates of inhibitors of blood coagu lation factor Xa [J]. Bioorg Med Chem Lett, 2004, 14 (14) 3763 - 3769.
  • 5ROEHRIG S,STRAUB A,POHLMANN J,et al. Discovery of the novel antithrombotic agent 5-chloro-N-(1 ( 5S ) -2-oxo-3-[ 4-( 3- oxomorpholin-4-yl) phenyl ] -1, 3-oxazolidin-5-yl I methyl ) thiophene-2-carboxamide(BAY59-7939) : an oral, direct factor Xa inhibitor[J]. J Med Chem ,2005,48 ( 19 ) :5900 - 5908.
  • 6拜尔公司.取代的噁唑烷酮和其在血液凝固领域中的应用:德国,CN00818966.8[P].2003-08-06.
  • 7陈华云(综述),王学锋(审校),王鸿利(审校).新型抗凝药物[J].国际输血及血液学杂志,2007,30(6):513-516. 被引量:2
  • 8高亚玥,王书杰.抗血栓药物的研究进展[J].中日友好医院学报,2009,23(4):250-253. 被引量:12
  • 9陈怡琳,施仲伟.抗凝新药利伐沙班临床研究进展[J].心血管病学进展,2009,30(5):810-813. 被引量:30
  • 10袁静,黄长江,张俊伟,张士俊,徐为人.利伐沙班的合成[J].中国新药杂志,2010,19(23):2185-2187. 被引量:18

共引文献47

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部